GlassScriptPhysician profile
Clifford V Morris
NPI 1558382994
$4,870.86
in general payments reported to CMS, 2019-2025
36 companies · $979 in 2025
The $979 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $229 · 2021: $437 · 2022: $767 · 2023: $1,078 · 2024: $906 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,944 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,943.51 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $625.75 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $584.85 | 2019-2025 | |
| Amgen INC. | $368.73 | 2022-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $309.86 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $301.64 | 2021-2024 | Xarelto |
| Pfizer INC. | $220.61 | 2019-2025 | |
| Irhythm Technologies, INC. | $204.78 | 2019-2024 | Zio Xt Patch, Zio At Patch |
| Baxter Healthcare | $202.31 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Boston Scientific Corporation | $190.27 | 2019-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| E.R. Squibb & Sons, L.L.C. | $162.43 | 2019-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $162.03 | 2022-2025 | |
| Novo Nordisk INC | $161.95 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $132.67 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $123.89 | 2021-2024 | Optimizer, Optimizer |
| Lexicon Pharmaceuticals, INC. | $101.79 | 2023-2024 | Inpefa |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.